tiprankstipranks
Trending News
More News >
Harbor BioSciences Inc (HRBR)
OTHER OTC:HRBR
US Market
Advertisement

Harbor BioSciences (HRBR) Ratios

Compare
19 Followers

Harbor BioSciences Ratios

HRBR's free cash flow for Q3 2024 was $-0.04. For the 2024 fiscal year, HRBR's free cash flow was decreased by $ and operating cash flow was $-0.04. See a summary of the company’s cash flow.
Ratios
TTM
Dec 23Dec 22Dec 21Dec 20
Liquidity Ratios
Current Ratio
3.53 3.88 2.16 2.10 1.41
Quick Ratio
3.36 3.81 2.10 2.01 1.28
Cash Ratio
0.20 0.50 0.41 1.85 1.16
Solvency Ratio
0.04 0.46 0.65 0.30 0.03
Operating Cash Flow Ratio
0.13 0.68 1.05 1.04 0.42
Short-Term Operating Cash Flow Coverage
0.00 4.92 8.54 2.93 1.33
Net Current Asset Value
$ 71.34M$ 118.02M$ 13.66M$ -72.88M$ -110.09M
Leverage Ratios
Debt-to-Assets Ratio
0.05 0.20 0.22 0.36 0.52
Debt-to-Equity Ratio
0.06 0.31 0.40 0.99 1.83
Debt-to-Capital Ratio
0.06 0.24 0.29 0.50 0.65
Long-Term Debt-to-Capital Ratio
0.03 0.22 0.23 0.43 0.59
Financial Leverage Ratio
1.30 1.57 1.83 2.70 3.52
Debt Service Coverage Ratio
307.50 2.92 9.96 2.52 0.37
Interest Coverage Ratio
-2.51K 18.62K 124.17 24.97 -9.46
Debt to Market Cap
0.07 0.80 0.69 7.73 113.94
Interest Debt Per Share
15.85 1.65 1.63 2.36 2.62
Net Debt to EBITDA
1.56 1.03 0.35 -0.04 8.88
Profitability Margins
Gross Profit Margin
-8.18%25.23%26.17%11.26%0.90%
EBIT Margin
-10.22%19.89%48.02%23.64%-6.48%
EBITDA Margin
1.62%14.85%58.06%37.61%3.09%
Operating Profit Margin
-14.95%19.89%42.48%23.31%-6.48%
Pretax Profit Margin
-10.23%19.26%47.68%22.71%-7.17%
Net Profit Margin
-10.02%13.92%37.41%21.38%-7.29%
Continuous Operations Profit Margin
-10.02%13.92%37.41%21.38%-7.29%
Net Income Per EBT
97.94%72.29%78.47%94.17%101.70%
EBT Per EBIT
68.40%96.84%112.25%97.40%110.57%
Return on Assets (ROA)
-4.96%10.22%23.19%11.35%-7.05%
Return on Equity (ROE)
-6.40%16.00%42.34%30.65%-24.79%
Return on Capital Employed (ROCE)
-8.87%17.65%34.00%15.48%-8.04%
Return on Invested Capital (ROIC)
-8.51%12.21%25.35%13.32%-7.30%
Return on Tangible Assets
-5.10%10.36%23.50%11.52%-7.19%
Earnings Yield
-1757.87%39.61%82.77%248.89%-1667.70%
Efficiency Ratios
Receivables Turnover
23.36 24.60 33.36 23.31 47.71
Payables Turnover
6.67 10.41 9.11 14.02 15.73
Inventory Turnover
18.18 45.86 35.15 27.80 33.41
Fixed Asset Turnover
1.60 2.43 1.73 1.18 1.50
Asset Turnover
0.50 0.73 0.62 0.53 0.97
Working Capital Turnover Ratio
1.21 1.91 2.73 3.64 6.71
Cash Conversion Cycle
-19.01 -12.25 -18.73 2.75 -4.63
Days of Sales Outstanding
15.63 14.84 10.94 15.66 7.65
Days of Inventory Outstanding
20.08 7.96 10.38 13.13 10.92
Days of Payables Outstanding
54.72 35.05 40.06 26.04 23.21
Operating Cycle
35.71 22.80 21.33 28.79 18.58
Cash Flow Ratios
Operating Cash Flow Per Share
7.45 0.97 1.73 1.33 0.47
Free Cash Flow Per Share
5.23 0.85 1.67 1.17 0.07
CapEx Per Share
2.22 0.12 0.07 0.16 0.39
Free Cash Flow to Operating Cash Flow
0.70 0.88 0.96 0.88 0.16
Dividend Paid and CapEx Coverage Ratio
2.40 7.14 21.27 7.70 1.19
Capital Expenditure Coverage Ratio
3.35 8.17 25.90 8.36 1.19
Operating Cash Flow Coverage Ratio
0.47 0.59 1.07 0.57 0.18
Operating Cash Flow to Sales Ratio
0.04 0.16 0.38 0.39 0.10
Free Cash Flow Yield
5.35%40.02%80.94%403.28%351.35%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
-0.06 2.52 1.21 0.40 -0.06
Price-to-Sales (P/S) Ratio
0.57 0.35 0.45 0.09 <0.01
Price-to-Book (P/B) Ratio
<0.01 0.40 0.51 0.12 0.01
Price-to-Free Cash Flow (P/FCF) Ratio
18.71 2.50 1.24 0.25 0.28
Price-to-Operating Cash Flow Ratio
0.13 2.19 1.19 0.22 0.05
Price-to-Earnings Growth (PEG) Ratio
<0.01 -0.05 <0.01 >-0.01 <0.01
Price-to-Fair Value
<0.01 0.40 0.51 0.12 0.01
Enterprise Value Multiple
36.62 3.40 1.13 0.19 9.02
Enterprise Value
59.81M 141.85M 162.58M 13.43M 73.51M
EV to EBITDA
36.62 3.40 1.13 0.19 9.02
EV to Sales
0.59 0.51 0.66 0.07 0.28
EV to Free Cash Flow
19.54 3.59 1.79 0.21 18.16
EV to Operating Cash Flow
13.71 3.15 1.73 0.18 2.88
Tangible Book Value Per Share
258.17 5.16 3.93 2.27 1.32
Shareholders’ Equity Per Share
267.22 5.27 4.03 2.36 1.41
Tax and Other Ratios
Effective Tax Rate
0.02 0.28 0.22 0.06 -0.02
Revenue Per Share
171.98 6.06 4.56 3.39 4.80
Net Income Per Share
-17.23 0.84 1.71 0.72 -0.35
Tax Burden
0.98 0.72 0.78 0.94 1.02
Interest Burden
1.00 0.97 0.99 0.96 1.11
Research & Development to Revenue
0.00 0.00 0.00 0.00 0.00
SG&A to Revenue
0.00 0.00 0.00 0.02 0.03
Stock-Based Compensation to Revenue
0.00 0.00 0.00 0.00 0.00
Income Quality
-0.43 1.15 1.02 1.84 -1.33
Currency in USD
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis